143 related articles for article (PubMed ID: 26905371)
41. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
42. Paradoxical simultaneous occurrence of amphetamine-induced conditioned taste aversion and conditioned place preference with the same single drug injection: a new "pre- and post-association" experimental paradigm.
Wang YC; Huang AC; Hsiao S
Pharmacol Biochem Behav; 2010 Mar; 95(1):80-7. PubMed ID: 20026166
[TBL] [Abstract][Full Text] [Related]
43. Changes in hippocampal CA1 population spikes following administration of delta-9-THC.
Weisz DJ; Gunnell DL; Teyler TJ; Vardaris RM
Brain Res Bull; 1982 Feb; 8(2):155-62. PubMed ID: 6279250
[TBL] [Abstract][Full Text] [Related]
44. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
[TBL] [Abstract][Full Text] [Related]
45. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
46. The modulation of cocaine-induced conditioned place preferences by alcohol: effects of cocaine dose.
Busse GD; Lawrence ET; Riley AL
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):149-55. PubMed ID: 14687869
[TBL] [Abstract][Full Text] [Related]
47. Conditioned taste avoidance and conditioned place preference induced by the third-generation synthetic cathinone eutylone in female sprague-dawley rats.
Jones RA; Huang S; Manke HN; Riley AL
Exp Clin Psychopharmacol; 2023 Dec; 31(6):1069-1079. PubMed ID: 37227884
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats.
Wiley JL; O'connell MM; Tokarz ME; Wright MJ
J Pharmacol Exp Ther; 2007 Mar; 320(3):1097-105. PubMed ID: 17172531
[TBL] [Abstract][Full Text] [Related]
49. Re-examination of amphetamine-induced conditioned suppression of tastant intake in rats: the task-dependent drug effects hypothesis.
Huang AC; Hsiao S
Behav Neurosci; 2008 Dec; 122(6):1207-16. PubMed ID: 19045940
[TBL] [Abstract][Full Text] [Related]
50. Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea.
Limebeer CL; Parker LA
Neuroreport; 1999 Dec; 10(18):3769-72. PubMed ID: 10716207
[TBL] [Abstract][Full Text] [Related]
51. Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
Craft RM; Britch SC; Buzitis NW; Clowers BH
Exp Clin Psychopharmacol; 2019 Aug; 27(4):338-347. PubMed ID: 31120286
[TBL] [Abstract][Full Text] [Related]
52. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
[TBL] [Abstract][Full Text] [Related]
53. Western diet consumption does not impact the rewarding and aversive effects of morphine in male Sprague-Dawley rats.
Huang S; Ghasem Ardabili N; Davidson TL; Riley AL
Physiol Behav; 2023 Oct; 270():114317. PubMed ID: 37541607
[TBL] [Abstract][Full Text] [Related]
54. An assessment of MDPV-induced place preference in adult Sprague-Dawley rats.
King HE; Wetzell B; Rice KC; Riley AL
Drug Alcohol Depend; 2015 Jan; 146():116-9. PubMed ID: 25468817
[TBL] [Abstract][Full Text] [Related]
55. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats.
Morel LJ; Giros B; Daugé V
Neuropsychopharmacology; 2009 Oct; 34(11):2469-76. PubMed ID: 19553915
[TBL] [Abstract][Full Text] [Related]
56. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
Haney M
Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
[TBL] [Abstract][Full Text] [Related]
57. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents.
Manwell LA; Ford B; Matthews BA; Heipel H; Mallet PE
J Pharmacol Toxicol Methods; 2014; 70(1):112-9. PubMed ID: 24956154
[TBL] [Abstract][Full Text] [Related]
58. delta9-tetrahydrocannabinol and the hippocampus: effects on CA1 field potentials in rats.
Vardaris RM; Weisz DJ
Brain Res Bull; 1977; 2(3):181-7. PubMed ID: 890504
[TBL] [Abstract][Full Text] [Related]
59. Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress.
Fokos S; Panagis G
J Psychopharmacol; 2010 May; 24(5):767-77. PubMed ID: 19406854
[TBL] [Abstract][Full Text] [Related]
60. Nicotine Enhances Footshock- and Lithium Chloride-Conditioned Place Avoidance in Male Rats.
Buffalari DM; Mollica JK; Smith TT; Schassburger RL; Rinaman L; Thiels E; Donny EC; Sved AF
Nicotine Tob Res; 2016 Sep; 18(9):1920-3. PubMed ID: 27178831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
